As broader approval for GLP-1 weight loss drugs spurs higher demand, it’s also causing employer drug spending to spike.
Related Posts
Jefferies downgrades Ford to underperform, says stock will struggle again in 2025
The new year could bring some more pullback for Ford, according to Jefferies.
Tencent challenges Amazon and Microsoft’s cloud dominance by tapping into its WeChat ecosystem
Tencent Cloud is increasingly leveraging the WeChat ecosystem to set itself apart from competitors, CEO Dowson Tong said.
Harris distances herself from Biden, bashes Trump in tense Fox News interview
Democratic presidential nominee Kamala Harris bashed Donald Trump in a tense interview with Fox News anchor Bret Baier while distancing herself from Joe Biden.